Surgient

company

About

Surgient offers self-service virtualization, automation and lab management solutions.

  • 251 - 500

Details

Last Funding Type
Series B
Last Funding Money Raised
$57M
Industries
Enterprise Software,Information Technology,Software,Training
Founded date
Jan 1, 1999
Number Of Employee
251 - 500
Operating Status
Active

Surgient, Inc. offers self-service virtualization automation and lab management solutions. The company offers Virtual Automation Platform, a software automation and management platform that helps enterprise IT organizations to provide self-service computing resources to users. Its virtualization solutions are used for software QA/test, training, sales, and marketing applications. The company’s Surgient Cloud Express combines cloud computing technology and implementation services to help organizations deploy on-premise clouds. Surgient also provides services, such as solution design and architecture, capacity and infrastructure planning, image and lab configuration planning, software installation and configuration, setup of initial images and lab configurations, software customization and integration, training for administrators and end-users, and custom reporting and analytics. The company serves hotels/hospitality, pharmaceutical, aerospace, insurance, software, financial services, healthcare, telecom, and hardware markets. Surgient, Inc. was formerly known as Surgient Networks, Inc. The company was founded in 1999 and is headquartered in Austin, Texas.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$57M
Surgient has raised a total of $57M in funding over 2 rounds. Their latest funding was raised on Jan 8, 2001 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 8, 2001 Series B $57M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Surgient is funded by 1 investors. Rock Mountain Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Rock Mountain Ventures Series B